Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Commission publishes latest device classification and borderline decisions

This article was originally published in Clinica

Executive Summary

The European Commission's Medical Devices Expert Group on borderline and classification cases has reached a consensus on the definition of a number of products that have "raised doubts". These doubts include devicesfor the determining bacterial contamination in blood products, eye drops, independent in-vivo dosimeters and biofunctional clothes, among other things. The expert group, whose work is to ensure a uniform approach in the regulation of medical devices, also made decisions on how applications for certain classification rules should be interpreted. For further details, see version 1.9 (dated March 2011) of the European Commission’s Manual on Borderline and Classification in the Community Regulatory Framework for Medical Devices, just published on the European Commission website: http://ec.europa.eu/consumers/sectors/medical-devices/files/wg_minutes_member_lists/version1_9_borderline_manual_en.pdf

You may also be interested in...



Second EU MDR Notified Body Designated In France

Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.

EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency

Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.

First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve

Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT097111

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel